
Glimepiride (4mg)
Active composition
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Glimestar 4 Tablet contains Glimepiride 4 mg, an oral antihyperglycemic agent belonging to the sulfonylurea class, indicated for the management of type 2 diabetes mellitus. Glimepiride functions by stimulating pancreatic beta cells to release insulin, thereby improving glycemic control in patients with inadequate response to diet and exercise alone. It enhances peripheral glucose uptake and decreases hepatic glucose production, contributing to overall blood glucose reduction. Glimestar 4 is typically prescribed as part of a comprehensive diabetes management plan, including diet modification and physical activity. The medication is administered once daily, preferably with breakfast or the first main meal, to optimize efficacy and minimize hypoglycemia risk. Dose adjustments should be individualized based on patient response and glycemic targets. Common adverse effects include hypoglycemia, weight gain, and gastrointestinal disturbances. Caution is advised in patients with hepatic or renal impairment, and it is contraindicated in type 1 diabetes, diabetic ketoacidosis, and hypersensitivity to sulfonylureas. Regular monitoring of blood glucose levels and periodic assessment of renal and hepatic function are recommended during therapy. Glimestar 4 Tablet should be used under medical supervision to ensure safe and effective diabetes management.
How to use Glimestar Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimestar 4 Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glimestar 4 Tablet.
High Risk
Glimestar 4 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glimestar 4 Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimestar 4 Tablet may be needed. Please consult your doctor. However, the use of Glimestar 4 Tablet is not recommended in patients with severe liver disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
Glimestar 4 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with Glimestar 4 Tablet
Consult Doctor
Glimestar 4 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glimestar 4 Tablet may be needed. Please consult your doctor. Use of Glimestar 4 Tablet is not recommended in patients with severe kidney disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
0 reviews for Glimestar 4 Tablet

Glimepiride (4mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Glimestar 4 Tablet contains Glimepiride 4 mg, an oral antihyperglycemic agent belonging to the sulfonylurea class, indicated for the management of type 2 diabetes mellitus. Glimepiride functions by stimulating pancreatic beta cells to release insulin, thereby improving glycemic control in patients with inadequate response to diet and exercise alone. It enhances peripheral glucose uptake and decreases hepatic glucose production, contributing to overall blood glucose reduction. Glimestar 4 is typically prescribed as part of a comprehensive diabetes management plan, including diet modification and physical activity. The medication is administered once daily, preferably with breakfast or the first main meal, to optimize efficacy and minimize hypoglycemia risk. Dose adjustments should be individualized based on patient response and glycemic targets. Common adverse effects include hypoglycemia, weight gain, and gastrointestinal disturbances. Caution is advised in patients with hepatic or renal impairment, and it is contraindicated in type 1 diabetes, diabetic ketoacidosis, and hypersensitivity to sulfonylureas. Regular monitoring of blood glucose levels and periodic assessment of renal and hepatic function are recommended during therapy. Glimestar 4 Tablet should be used under medical supervision to ensure safe and effective diabetes management.
How to use Glimestar Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimestar 4 Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glimestar 4 Tablet.
High Risk
Glimestar 4 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glimestar 4 Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimestar 4 Tablet may be needed. Please consult your doctor. However, the use of Glimestar 4 Tablet is not recommended in patients with severe liver disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
Glimestar 4 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with Glimestar 4 Tablet
Consult Doctor
Glimestar 4 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glimestar 4 Tablet may be needed. Please consult your doctor. Use of Glimestar 4 Tablet is not recommended in patients with severe kidney disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
0 reviews for Glimestar 4 Tablet













